Deal History
About us
Selskabet
Team
Vores kontorer
Globalscope
Worldwide
Canada
Denmark
France
Germany
Poland
Sweden
United Kingdom
USA
Services
Corporate Finance
Debt Advisory
Equity Research
Vækstkapital
IPO Strategi og forberedelse
Industrifokus
Business Services
Consumer / Retail / E-commerce
Industrials
Life Science og Healthcare
Software
Career
Events
Insights
News
Company news
Deal news
Carlsquare in the Media
Newsletter
Kontakt
Newsletter
DA
INT
DE
FR
SV
US
Main menu button
Team
Deals
Kontakt
Team
Deals
Kontakt
News
Alle
Company news
Deal News
Equity Research
Events
I Medier
Insights
Macro and markets
Alle
Abera Bioscience
All for One Group
ALM Equity
Alzecure Pharma
Angler Gaming
Arctic Minerals
Biosergen
Candles Scandinavia
Carlsquare
CDON
CellaVision
CSAM Health Group
Elicera Therapeutics
Enrad
Frequentis
Future Gaming
GHP Specialty Care
Hanza
Herantis Pharma
Immunovia
InCoax
Kancera
KlaraBo
Lohilo Foods
Lokotech
Medclair Invest
Midsummer
Modus Therapeutics
Moninvent
Nischer Properties
Nosa Plugs
Observit
Orion Corporation
Risk Intelligence
SBB i Norden
Spotlight Group
Svenska Aerogel
Teneo AI
Thinc Collective
Viva Wine Group
White Pearl Technology Group
Zinzino
Alle
23 okt 2019
Analysis, AdderaCare: A fresh start
Equity Research
22 okt 2019
Q3 2019 preview SBB i Norden: Stability should be rewarded
Equity Research
14 okt 2019
Analysis Kopy Goldfields: New exploration
Equity Research
10 okt 2019
Analysis Calliditas: Great value can be released
Equity Research
01 okt 2019
Analysis Miris: Still waiting for the US
Equity Research
16 sep 2019
Analysis CLS: Awaiting Thermoguide
Equity Research
11 sep 2019
Analysis Amasten: Construction of new residentials create value
Equity Research
10 sep 2019
Analysis Brighter: News creates lower risk
Equity Research
04 sep 2019
Analysis Speqta: Strong growth in client base
Equity Research
04 sep 2019
Analysis MultiDocker: Weak result, though improved gross margins
Equity Research
03 sep 2019
Analysis VibroSense: A case of nerves
Equity Research
02 sep 2019
Analysis Biovica: Good progress in FDA discussions
Equity Research
29 aug 2019
Analysis Consilium: Proven result improvement
Equity Research
29 aug 2019
Analysis, New Wave Group: Investment for growth
Equity Research
29 aug 2019
Analysis Aspire: Growth in line with expectation
Equity Research
29 aug 2019
Analysis, Cell Impact: Financing creates opportunities
Equity Research
29 aug 2019
Analysis SolTech: Strong delivery from acquisition
Equity Research
27 aug 2019
Analysis NeuroVive: Fast Track and clinical progress
Equity Research
27 aug 2019
Analysis Flowscape: Important order from the US
Equity Research
26 aug 2019
Analysis Netmore: Akelius-deal a catalyst
Equity Research
1
…
41
42
43
44
45
…
64